Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Trends in Endocrinology and Metabolism: TEM|July 13, 2010
Central players in inherited lipodystrophiesEllen H Jeninga, Eric Kalkhoven
Trends in Endocrinology and Metabolism: TEM|September 15, 2009
Functional implications of genetic variation in human PPARgammaEllen H Jeninga, Mark Gurnell, Eric Kalkhoven
Molecular & Cellular Proteomics : MCP|July 15, 2009
Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactorArjen Koppen, Rene Houtman, Dirk Pijnenburg, et al.
The Journal of Biological Chemistry|July 28, 2009
Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81)Ellen H Jeninga, Anne Bugge, Ronni Nielsen, et al.
Scientific Reports|February 23, 2012
The metabolic footprint of aging in miceRiekelt H Houtkooper, Carmen Argmann, Sander M Houten, et al.
The Journal of Clinical Endocrinology and Metabolism|February 15, 2007
Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gammaHoushang Monajemi, Lin Zhang, Gang Li, et al.
Molecular Endocrinology (Baltimore, Md.)|February 22, 2007
Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophyEllen H Jeninga, Olivier van Beekum, Aalt D J van Dijk, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2002
Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing bloodJasper A Remijn, Ya-Ping Wu, Ellen H Jeninga, et al.
Molecular and Cellular Biology|July 15, 2009
The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiationKoen M A Dreijerink, Radhika A Varier, Olivier van Beekum, et al.
Pageof 2